Literature DB >> 18940810

S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid binding.

Yu Ishima1, Takaaki Akaike, Ulrich Kragh-Hansen, Shuichi Hiroyama, Tomohiro Sawa, Ayaka Suenaga, Toru Maruyama, Toshiya Kai, Masaki Otagiri.   

Abstract

Binding of oleate to S-nitrosylated human serum albumin (SNO-HSA) enhances its cytoprotective effect on liver cells in a rat ischemia/reperfusion model. It enhances the antiapoptotic effect of SNO-HSA on HepG2 cells exposed to anti-Fas antibody. To identify some of the reasons for the increased cytoprotective effects, additional experiments were performed with glutathione and HepG2 cells. As indicated by 5,5'-dithiobis-2-nitrobenzoic acid binding, the addition of oleate increased the accessibility of the single thiol group of albumin. Binding of increasing amounts of oleate resulted in increasing and more rapid S-transnitrosation of glutathione. Likewise, binding of oleate, or of a mixture of endogenous fatty acids, improved S-denitrosation of SNO-HSA by HepG2 cells. Oleate also enhanced S-transnitrosation by HepG2 cells, as detected by intracellular fluorescence of diaminofluorescein-FM. All of the S-transnitrosation caused by oleate binding was blocked by filipin III. Oleate also increased, in a dose-dependent manner, the binding of SNO-HSA labeled with fluorescein isothiocyanate to the surface of the hepatocytes. A model in two parts was worked out for S-transnitrosation, which does not involve low molecular weight thiols. Fatty acid binding facilitates S-denitrosation of SNO-HSA, increases its binding to HepG2 cells and greatly increases S-transnitrosation by hepatocytes in a way that is sensitive to filipin III. A small nitric oxide transfer takes place in a slow system, which is unaffected by fatty acid binding to SNO-HSA and not influenced by filipin III. Thus, fatty acids could be a novel type of mediator for S-transnitrosation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940810      PMCID: PMC2596408          DOI: 10.1074/jbc.M807009200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.

Authors:  Yasuomi Yamasaki; Kazuya Sumimoto; Makiya Nishikawa; Fumiyoshi Yamashita; Kiyoshi Yamaoka; Mitsuru Hashida; Yoshinobu Takakura
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

Review 2.  Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

Authors:  Ulrich Kragh-Hansen; Victor Tuan Giam Chuang; Masaki Otagiri
Journal:  Biol Pharm Bull       Date:  2002-06       Impact factor: 2.233

3.  Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation.

Authors:  Yu Ishima; Takaaki Akaike; Ulrich Kragh-Hansen; Shuichi Hiroyama; Tomohiro Sawa; Toru Maruyama; Toshiya Kai; Masaki Otagiri
Journal:  Biochem Biophys Res Commun       Date:  2007-10-26       Impact factor: 3.575

4.  Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids.

Authors:  I Petitpas; T Grüne; A A Bhattacharya; S Curry
Journal:  J Mol Biol       Date:  2001-12-14       Impact factor: 5.469

5.  In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time.

Authors:  H Watanabe; K Yamasaki; U Kragh-Hansen; S Tanase; K Harada; A Suenaga; M Otagiri
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

6.  Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function.

Authors:  Michael S Crane; Richard Ollosson; Kevin P Moore; Adriano G Rossi; Ian L Megson
Journal:  J Biol Chem       Date:  2002-09-23       Impact factor: 5.157

7.  Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants.

Authors:  Y A Gryzunov; A Arroyo; J-L Vigne; Q Zhao; V A Tyurin; C A Hubel; R E Gandley; Y A Vladimirov; R N Taylor; V E Kagan
Journal:  Arch Biochem Biophys       Date:  2003-05-01       Impact factor: 4.013

8.  Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury.

Authors:  N Ikebe; T Akaike; Y Miyamoto; K Hayashida; J Yoshitake; M Ogawa; H Maeda
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

9.  Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway.

Authors:  Jürgen Pohl; Axel Ring; Wolfgang Stremmel
Journal:  J Lipid Res       Date:  2002-09       Impact factor: 5.922

10.  S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release.

Authors:  Seth Hallström; Harald Gasser; Christoph Neumayer; Alexander Fügl; Joseph Nanobashvili; Andrzej Jakubowski; Ihor Huk; Günther Schlag; Tadeusz Malinski
Journal:  Circulation       Date:  2002-06-25       Impact factor: 29.690

View more
  13 in total

Review 1.  Protein denitrosylation: enzymatic mechanisms and cellular functions.

Authors:  Moran Benhar; Michael T Forrester; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-09       Impact factor: 94.444

2.  Modulation of the reactivity of the thiol of human serum albumin and its sulfenic derivative by fatty acids.

Authors:  María José Torres; Lucía Turell; Horacio Botti; Laura Antmann; Sebastián Carballal; Gerardo Ferrer-Sueta; Rafael Radi; Beatriz Alvarez
Journal:  Arch Biochem Biophys       Date:  2012-03-19       Impact factor: 4.013

Review 3.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

4.  Albumin and mammalian cell culture: implications for biotechnology applications.

Authors:  Geoffrey L Francis
Journal:  Cytotechnology       Date:  2010-04-06       Impact factor: 2.058

Review 5.  Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

Authors:  Yaqi Wo; Elizabeth J Brisbois; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomater Sci       Date:  2016-05-26       Impact factor: 6.843

6.  Redox-sensitivity and site-specificity of S- and N- denitrosation in proteins.

Authors:  Frances L Jourd'heuil; Anthony M Lowery; Elaina M Melton; Sanie Mnaimneh; Nathan S Bryan; Bernadette O Fernandez; Joo-Ho Park; Chung-Eun Ha; Nadhipuram V Bhagavan; Martin Feelisch; David Jourd'heuil
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

7.  S-nitrosation of cellular proteins by NO donors in rat embryonic fibroblast 3Y1 cells: factors affecting S-nitrosation.

Authors:  Norihiro Ryuman; Nobuo Watanabe; Takao Arai
Journal:  Oxid Med Cell Longev       Date:  2011-08-17       Impact factor: 6.543

8.  A novel S-sulfhydrated human serum albumin preparation suppresses melanin synthesis.

Authors:  Mayumi Ikeda; Yu Ishima; Ryo Kinoshita; Victor T G Chuang; Nanami Tasaka; Nana Matsuo; Hiroshi Watanabe; Taro Shimizu; Tatsuhiro Ishida; Masaki Otagiri; Toru Maruyama
Journal:  Redox Biol       Date:  2017-10-11       Impact factor: 11.799

9.  Superoxide dismutase as a novel macromolecular nitric oxide carrier: preparation and characterization.

Authors:  Ssu-Han Chen; Shih-Jiuan Chiu; Teh-Min Hu
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

10.  Evaluation of in vitro culture systems for the maintenance of microfilariae and infective larvae of Loa loa.

Authors:  Denis Zofou; Fanny Fri Fombad; Narcisse V T Gandjui; Abdel Jelil Njouendou; Arnaud Jonas Kengne-Ouafo; Patrick W Chounna Ndongmo; Fabrice R Datchoua-Poutcheu; Peter A Enyong; Dizzle Tayong Bita; Mark J Taylor; Joseph D Turner; Samuel Wanji
Journal:  Parasit Vectors       Date:  2018-05-02       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.